LRP1 and cancer: Similarly, several other receptors, such as gonadotropin-releasing hormone (GnRH), LDL receptor-related protein 1 (LRP1), somatostatin subtype-2, and transferrin, are being targeted for delivery of chemotherapeutics to the cancer site [8].